Concepedia

Author

Yvette H. van Beurden

Amsterdam UMC Location Vrije Universiteit Amsterdam

Also Known As

Evelien Dekker, Y H van Beurden, Y. H. Van Beurden, Y. H. van Beurden, Y.H. van Beurden, Yvette Beurden, Yvette H van Beurden, Yvette H. Van Beurden, Yvette H. van Beurden, van Beurden, Yvette H.

25

Publications

679

Citations

13

H-Index

13

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit AmsterdamLeiden University Medical CenterAmsterdam University Medical CentersMedisch Centrum HaaglandenAmsterdam UMC Location University of Amsterdam
YH

About

Yvette H. van Beurden is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, clinical microbiology, and antimicrobial resistance.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

40

2

Epidemiology

2

2

40

3

Public Health

1

1

19

4

Microbiology

1

1

21

5

Antibiotics

1

1

21

Yvette H. van Beurden

×

10

Publications

310

Citations

10

H-Index

YearCitations

Complications, effectiveness, and long term follow‐up of fecal microbiota transfer by nasoduodenal tube for treatment of recurrent <i>Clostridium difficile</i> infection

Yvette H. van Beurden, Pieter F. de Groot, Els van Nood,

United European Gastroenterology Journal

2016

74

Faecal microbiota transplantation for <i>Clostridioides difficile</i> infection: Four years’ experience of the Netherlands Donor Feces Bank

Elisabeth M. Terveer, Karuna E.W. Vendrik, Rogier E. Ooijevaar,

United European Gastroenterology Journal

2020

61

Serendipity in Refractory Celiac Disease: Full Recovery of Duodenal Villi and Clinical Symptoms after Fecal Microbiota Transfer

Yvette H. van Beurden, Tom van Gils, Nienke A. Van Gils,

Journal of Gastrointestinal and Liver Diseases

2016

54

Host factors are more important in predicting recurrent Clostridium difficile infection than ribotype and use of antibiotics

Yvette H. van Beurden, S. Nezami, Chris J. Mulder,

Clinical Microbiology and Infection

2017

21

Diagnostic yield of repeat sampling with immunoassay, real-time PCR, and toxigenic culture for the detection of toxigenic Clostridium difficile in an epidemic and a non-epidemic setting

Joffrey van Prehn, Christina M. J. E. Vandenbroucke‐Grauls, Yvette H. van Beurden,

European Journal of Clinical Microbiology & Infectious Diseases

2015

19

Cost analysis of an outbreak of Clostridium difficile infection ribotype 027 in a Dutch tertiary care centre

Yvette H. van Beurden, Marije K. Bomers, Suzanne D. van der Werff,

Journal of Hospital Infection

2016

19

Ten-Year Follow-Up of Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection from a Randomized Controlled Trial and Review of the Literature

Rogier E. Ooijevaar, Els van Nood, Abraham Goorhuis,

Microorganisms

2021

18

External validation of two prediction tools for patients at risk for recurrent <i>Clostridioides difficile</i> infection

Tessel M. van Rossen, Laura J. van Dijk, Martijn W. Heymans,

Therapeutic Advances in Gastroenterology

2021

17

An Outbreak of Clostridium difficile Ribotype 027 Associated with Length of Stay in the Intensive Care Unit and Use of Selective Decontamination of the Digestive Tract: A Case Control Study

Yvette H. van Beurden, Olaf M. Dekkers, Marije K. Bomers,

PLoS ONE

2016

16

External Validation of Three Prediction Tools for Patients at Risk of a Complicated Course of <i>Clostridium difficile</i> Infection: Disappointing in an Outbreak Setting

Yvette H. van Beurden, M.P.M. Hensgens, Olaf M. Dekkers,

Infection Control and Hospital Epidemiology

2017

11

Page 1